Celldex Therapeutics
Price & Volume
Stats
See more52W Range | $18.61-$47 |
Market Cap | $1.3B |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $7M |
Revenue Growth (YoY) | -71.6% |
Gross Profit (12 Mos) | -$156.5M |
Diluted EPS | -$2.45 |
News
See moreYahoo Finance • 20 days ago
Celldex Therapeutics to Present at Upcoming Investor Conferences
Yahoo Finance • 21 days ago
Celldex Therapeutics Presents Positive Preclinical Data from Inflammatory Bispecific Antibody Program CDX-622 at AAAAI 2025
Yahoo Finance • 22 days ago
Celldex Therapeutics Presents Positive Results from Barzolvolimab Phase 2 Studies in Patients with Chronic Urticaria Demonstrating Improved Disease Control and Quality of Life at AAAAI 2025
Yahoo Finance • 24 days ago
Celldex Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update
About
CEO | Mr. Anthony S. Marucci M.B.A. |
CFO | Mr. Sam Martin CPA |
Address | Perryville III Building, Hampton, NJ, United States, 08827 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 186 |
